Related Experiment Video

Updated: Dec 21, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Strategic Combination Therapies for Ovarian Cancer

Xinran Li1, Angel S N Ng1, Victor C Y Mak1

  • 1Li Ka Shing Faculty of Medicine, School of Biomedical Sciences, The University of Hong Kong, Pok Fu Lam, Hong Kong.

Current Cancer Drug Targets
|May 12, 2020
PubMed

Insights

Ovarian cancer treatments are improving with new combination therapies. Research reviews preclinical data and clinical trials for novel ovarian cancer drug combinations to enhance patient outcomes.

Area of Science:

  • Gynecologic Oncology
  • Cancer Therapeutics
  • Translational Oncology

Background:

  • Ovarian cancer is a leading cause of cancer death in women globally.
  • Recurrence after surgery and chemotherapy contributes to poor survival rates.
  • Recent advances include targeted therapies like antiangiogenic agents and PARP inhibitors.

Purpose of the Study:

  • To review preclinical data and ongoing clinical trials of combination therapies for ovarian cancer.
  • To explore how novel therapeutic combinations can improve clinical outcomes.
  • To assess the potential of emerging modalities to reshape ovarian cancer treatment.

Main Methods:

  • Review of preclinical studies on ovarian cancer combination therapies.
  • Analysis of ongoing clinical trials investigating novel treatment strategies.
  • Synthesis of data on targeted therapies, DNA-damaging agents, and immunotherapies.

Main Results:

  • Combination approaches target multiple cancer pathways for additive or synergistic effects.
  • Emerging therapies show promise in preclinical settings.
  • Numerous clinical trials are evaluating these novel combinations.

Conclusions:

  • Combination therapies represent a promising strategy to overcome ovarian cancer recurrence and improve survival.
  • Targeted agents, DNA-damaging drugs, and immunotherapies are key components of novel combinations.
  • These emerging treatment modalities have the potential to significantly alter the ovarian cancer treatment landscape.
Keywords:
Chemotherapycombination treatmentimmunotherapyovarian cancerpoly (ADP-ribose) polymerase inhibitorstargeted therapy

More Related Videos

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K